Pituitary Dwarf Treatment Market 2024 Opportunity Assessment, Production Analysis, Growth Rate And Forecast To 2033

"The new report published by The Business Research Company, titled Pituitary Dwarf Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the pituitary dwarf treatment market size has grown rapidly in recent years. It will grow from $4.76 billion in 2023 to $5.52 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The pituitary dwarf treatment market size is expected to see rapid growth in the next few years. It will grow to $9.4 billion in 2028 at a compound annual growth rate (CAGR) of 14.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12923&type=smp

Growth Hormone Deficiency Drives Growth In The Pituitary Dwarf Treatment Market
The growing prevalence of growth hormone deficiency is expected to propel the growth of the pituitary dwarf treatment market going forward. Growth hormone deficiency (GHD) is a medical condition characterized by the pituitary gland's inadequate production or secretion of growth hormone (GH). The pituitary dwarf treatment provides hormonal therapies that increase growth and bone health, regulate metabolism and improve the quality-of-life suffering from dwarfism and growth hormone deficiency. For instance, in January 2021, according to the European Medicines Agency (EMA), a UK-based decentralized agency, an estimated 6,000 adults will be diagnosed with adult growth hormone deficiency (AGHD) each year in the US. Therefore, the growing prevalence of growth hormone deficiency is driving the growth of the pituitary dwarf treatment market.

Market Focus On Innovative Products Drives Growth In Pituitary Dwarf Treatment
Major companies operating in the pituitary dwarf treatment market are focusing on developing innovative products to sustain their position in the market. For instance, in April 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, introduced Sogroya (somapacitan-beco) injections of 5 mg, 10 mg, or 15 mg approved by the Food and Drug Administration (FDA), a US-based government agency. Sogroya treats children aged 2.5 years and older with growth deficiencies due to insufficient endogenous growth hormone secretion. With this additional indication, Sogroya is now the only once-weekly growth hormone (GH) medication available for children and adults.

The pituitary dwarf treatment market covered in this report is segmented -

1) By Type: Pituitary Dwarfism Type I; Pituitary Dwarfism Type II; Pituitary Dwarfism Type III; Pituitary Dwarfism Type IV; Other Types
2) By Treatment: Surgery; Additional Therapy; Drugs; Other Treatments
3) By Route Of Administration: Parenteral; Other Routes Of Administrations
4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12923&type=discount

Major players in the pituitary dwarf treatment market are Pfizer Inc., Merck and Co Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, H. Lundbeck A/S, Mylan N.V., Teva Pharmaceutical Industries Ltd., Ipsen Pharma S.A., Genentech Inc., Apotex Inc., Cipla Limited, Ferring Pharmaceuticals, Anhui Anke Biotechnology (Group) Co Ltd., Amneal Pharmaceuticals LLC., BioMarin Pharmaceutical Inc., Biopartners GmbH, Elekta AB, Xiamen Amoytop Biotech Co Ltd., Lifetech Labs, Alnylam Pharmaceuticals Inc., GeneScience Pharmaceuticals Co Ltd., Armata Pharmaceuticals Inc., Alkermes Plc.

Contents of the report:
1. Executive Summary
2. Pituitary Dwarf Treatment Market Report Structure
3. Pituitary Dwarf Treatment Market Trends And Strategies
4. Pituitary Dwarf Treatment Market - Macro Economic Scenario
5. Pituitary Dwarf Treatment Market Size And Growth
…..
27. Pituitary Dwarf Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/pituitary-dwarf-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.